Intensive care has become important for the treatment of patients with cancer. However, the prognosis of these patients is considered poor a priori and decisions to admit a patient with cancer to the intensive care unit (ICU) are still source of controversy between oncologists and intensivists. The outcome of severely ill cancer patients does not depend solely on the causes that determine the admission to the ICU, but it also depends on cancer-and anticancer-related characteristics, such as performance status and cancer status.
Introduction
The main reasons for admission to the ICU are Cancer is increasing major cause of morbidity and 1) postoperative care after major surgical resections, mortality worldwide. [1] [2] [3] The number of new cases of cancer 2) severe cancer or chemo-radiation-related complications in the world estimated for the year of 2020 will be more and 3) concurrent severe acute illnesses. [4, 5] Usually, than 15 million, with deaths increasing to 12 million. It is patients are admitted to the ICU when they have also expected the burden of cancer in terms of incidence, a malignancy with a reasonable chance of cure or morbidity and mortality will be substantially more severe control and, especially, if the acute illness is potentially in developing countries than developed ones. [3] However, reversible. Patients' wishes and personal values must over the last decades advances in cancer treatment were be respected regarding decisions to initiate and to translated into enhanced possibilities of cure or disease forgo life-sustaining therapies as well as those related control as well as improved survival and quality of life. [1, 2] to the appropriateness of aggressive therapy as As consequence, intensive care has become essential for invasive mechanical ventilation, dialysis and cardioAbstract cancer patients and most institutions that care for these pulmonary resuscitation. [5, 6] Nevertheless, the admission patients have an intensive care unit (ICU). [4, 5] of patients with cancer to the ICU is still a matter of substantial controversy among oncology consultants and the ICU team. The prognosis of these patients is usually considered dismal a priori. This inappropriate notion is responsible for a considerable part of the ICU refusals of patients with cancer, especially in general hospitals. Moreover, these decisions are frequently stained by prejudice since patients without cancer, but
Free full text available from www.ijccm.org suffering from chronic diseases with similar prognoses, have better chances of being admitted to the ICU and receiving advanced life-support compared to patients with cancer. [7, 8] On the other hand, with the institution of full code, prolonging the life of patients with dismal chances of recovery may result in plain medical futility. This situation imposes a heavy burden of suffering and frustration to the patient and his beloved ones as well as the ICU team. Additionally, the ever-growing cost of intensive care and scores. [21] [22] [23] Recently, we have validated the SAPS 3 admission prognostic model in patients with cancer in need of intensive care. [25] Although, we have found a good performance for this new prognostic model in that single-center study, additional studies are necessary.
Severity of Illness, Acute Organ Dysfunctions, Mechanical Ventilation and Renal
Replacement Therapy the limited availability of ICU beds lead us to consider The severity of acute physiologic derangements and suitably on the rationing of resources. [9, 10] acute organ dysfunctions are the main predictors of shortterm mortality in critically ill patients with cancer. [11, 14, 17, [26] [27] [28] [29] [30] [31] [32] Briefly, the evaluation of the appropriateness of Acute respiratory failure (ARF) with the need of invasive admitting a patient with cancer to the ICU should be mechanical ventilation (MV) is usually associated with supported by a better knowledge of a complex array a poor outcome. [14, 20, 21, 28, 30, [32] [33] [34] Until recently, mortality of clinical factors related to the acute illness, cancer rates in patients with cancer and respiratory failure characteristics and patients`/families' expectations. were typically higher than 75%. [10, 27, [35] [36] [37] However, in the This is even more important if we acknowledge that the last decade, significant improvement in the outcomes mortality of critically-ill patients with cancer is substantially of cancer patients with ARF was observed; [11, 28, 29, 38, 39] higher than of non-cancer patients. [11] [12] [13] [14] a major change that was ascribed to the application of low-tidal volume ventilation [40] and the use of noninvasive This article reviews the main aspects related to the ventilation (NIV) in immunosupressed patients [41] and evaluation of the prognosis of critically-ill patients with acutely ill cancer patients. [42] In the studies of Hilbert et cancer. Studies were selected through a careful search al [41] and Azoulay et al [38] patients treated initially with in the Medline database accessed by Pubmed (www. NIV had significantly lower mortality rates as compared pubmed.gov) in February 2007. Descriptors were: cancer, to those treated with conventional MV (50% vs. 81% outcome, mortality, intensive care organ dysfunction and 44% vs. 71%, respectively). Yet, many patients are and mechanical ventilation. Other references were also admitted to the ICU with severe respiratory derangements individually included after the initial search.
or too late in the course of their acute disease limiting the use of NIV. [29, 39] Early identification of respiratory distress
The Use of Prognostic Scores
and good patient selection is essential to augment the Severity of illness scores has been extensively benefits of NIV. [38, 41] Conversely, the recognition of used in the evaluation of the prognosis of critically-early signs of NIV failure is crucial as prolonging NIV in ill patients. Despite lacking the ability of predicting patients who require subsequent endotracheal intubation individual outcome, [15] prognostic scores may be useful is associated with a worse outcome as compared to in prognostic discussion, improvement of resource patients who received conventional MV as a fi rst choice allocation, stratification for clinical trials and evaluation of therapy for ARF. [42, 43] Even in patients with lung cancer of the quality of ICU services.
[16] General scores usually have a poor performance in critically-ill patients with cancer due to inadequate calibration and underestimation of mortality. [17] [18] [19] [20] [21] [22] [23] [24] The limitation of the general scores lead to the development of an specific score for acutely ill patients with cancer, the cancer mortality model (CMM).
[20] The CMM uses variables related to physiologic derangements and also performance status, evidence of disease progression or relapse and treatment with allogeneic bone marrow transplant (BMT). However, the CMM performance was not superior to those of general in whom ARF is considered a terminal complication, the prognosis of seems to be improving. In a recent cohort of 143 patients with lung cancer admitted at two ICUs because of severe acute medical illnesses, MV was used in 100 patients and overall hospital mortality was 59%. [44] It is important to stress that among these 100 ventilated patients only 13 were initially treated with NIV.
Acute kidney injury (AKI) is also a common complication in patients with cancer and may occur as consequence of multiple causes, such as of the cancer itself (myeloma kidney, urinary tract obstruction), its treatment (acute tumor lysis syndrome, drug induced nephropathy) and associated severe complications (sepsis, hypercalcemia). AKI is associated with a worse prognosis and can impose limitations to the institution of the appropriate regimen of chemotherapy. In addition, in critically-ill patients with cancer, AKI usually occurs in the context of multiple organ dysfunctions and is associated with high mortality rates, [45] [46] [47] [48] raising concerns on the appropriateness of renal replacement therapy (RRT), its timing and method of determinant of ICU refusal, [51] elderly patients still have a higher probability of refusal of ICU admission [52] and of having decisions to forgo life-sustaining therapies.
[53]
The performance status is routinely used to evaluate the functional capacity and autonomy in patients with cancer. A compromised performance status (Karnofsky < 70 or Eastern Cooperative Oncology Group scale 3-4) before hospital admission was associated with increased short and long-term mortality rates in ICU patients with capacity and with higher prevalence of chronic malignancies. Solid tumors are usually staged according diseases including cancer. The impact of age on to disease extension as locoregional or metastatic choice. Moreover, AKI was independently associated with cancer. [20, 29, 30, 50, 54] longer duration of weaning from MV.
[48] In a recent cohort of 309 patients with cancer and AKI, older age, poor
Patients with cancer often present with severe performance status, cancer recurrence or progression comorbidities that may have implications in their and the severity of organ failures were independently outcomes. [55, 56] The presence of comorbidities significantly associated with increased mortality.
[46] The timing of increases the risk of complications related to chemotherapy institution of RRT seems to be an important issue to and other anticancer therapies, which may impose take into account as there were no survivors among limitations to the administration of them. [56] patients in whom RRT was initiated after the fourth day data about the impact of comorbidities on the prognosis of ICU admission.
[46] In the study of Darmon et al [45] the of critically-ill patients with cancer are scant. A single deterioration of kidney function with the need of RRT after study has focused on the use of comorbidities indexes the first day ICU stay was the main predictive factor for in this patient population. [30] In that study, 50% of the patients had comorbid conditions and the presence of severe comorbidities evaluated by the adult comorbidity
Age, Performance Status and evaluation (ACE-27) was independently associated with
Comorbidities six-month mortality. Moreover, the ACE-27 was a better Life expectancy is increasing globally.
[49] According to instrument to measure comorbidities in critically ill patients the World Health Organization report " between 1970 and with cancer than the Charlson comorbidity index. [30] 2025, a growth in older persons of some 694 million is expected and in 2025, there will be a total of about 1.2
Cancer-related Characteristics
billion people over the age of 60". [49] Considering that The diagnosis of cancer encompasses a wide array elderly patients are the main users of the health system, of diseases with diverse clinical characteristics and such demographic changes will have clear impact on the biological behavior. Designing studies to evaluate allocation of resources and public health policies. specific groups of critically ill patients with cancer is a difficult task. Traditionally, patients have been grouped Ageing is associated with the reduction of physiologic in two large categories: solid tumors and hematological Available hospital death. the mortality of critically-ill cancer patients remains controversial. [14, 20, 27, 29, 30, 33, 34, 50] However, the interpretation of these results should be done with caution, as selection bias on ICU admission is inherent to the triage process. In a study of our group, age was an independent prognostic factor. [50] Nevertheless, the overall effect of age on the six-month survival was modest, but the impact of other covariates such as performance status and comorbidities on the outcomes was higher in elderly patients. [50] Regrettably, while age should not be the sole disease. Conversely, the classification and staging of hematological malignancies is much more complex; most authors choose to separate them into large categories as multiple myeloma, Hodgkin's disease, leukemia and non-Hodgkin's lymphoma. [14, 17, 30, 36, 57] BMT patients are usually studied in separate regardless of the primary site of cancer, as they have significant peculiarities and are usually classified in two groups according to the type of BMT procedure (autologous or allogeneic). [18, 27, 57] BMT patients admitted to the ICU remain a population with exceedingly high mortality rates (>85%), especially in case of allogeneic BMT, despite a slightly better prognosis observed in recent years. [11, 20, 27, 36, 57] Until recently the outcomes of patients with neutropenia and hematological malignancies were considered grim especially in the setting of ARF in need of MV. [27, 35, 37] However, recent studies have observed that neither the type of cancer nor the presence of neutropenia were critically-ill patients with cancer by studying longer follow-ups, specific patient populations, incorporation of multidimensional methods of evaluation and HRQOL. The knowledge of characteristics associated with prognosis may be of assistance in the clinical decision-making process and in informing patients and family members. According to expert opinions, patients should be admitted to the ICU when clinicians are unsure of their prognosis and the consequence appropriateness of advanced associated with worse outcomes and might have lost their support. In this case, full code should be applied for a impact on the mortality. [11, 14, 29, 30, 33, 38, 57] The rational use of short period (three to five days) after which the patient granulocyte colony stimulating factors have reduced both will be re-evaluated. [64, 65] The course of organ failures and the risk and duration of neutropenia in patients receiving response to therapy will be considered in deciding for chemotherapy [58] and early recovery of the neutrophil the maintenance or withdrawal of support after a careful count is associated with better prognosis.
[34] Moreover, discussion involving oncologists and patient's family.It is starting chemotherapy in the ICU can be life-saving to essential to re-emphasize that no single characteristic or patients with a first presentation of a malignancy when score should be used to predict prognosis on individual infection or organ failure is present. [32, 59] However, on the basis and as a sole parameter for ICU triage procedures. other hand, disease recurrence or progression (of either The most important aspect should be not to refuse solid or hematological malignancies) is a key predictor intensive care to those who might potentially benefit of mortality. [20, 27, 29, 30, 44, 50, 57] from it.
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Conclusions
The evaluation of prognosis is essential for the clinical care of ICU patients and for the appraisal of the impact of new therapeutic interventions. It is also crucial to expand the current knowledge on the prognosis of ) .
